Global Korea Genomics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Korea Genomics market report explains the definition, types, applications, major countries, and major players of the Korea Genomics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • OXFORD NANOPORE TECHNOLOGIES

    • QIAGEN

    • EUROFINS SCIENTIFIC

    • BIO-RAD LABORATORIES

    • PACIFIC BIOSCIENCES OF CALIFORNIA

    • F HOFFMANN-LA ROCHE

    • THERMO FISHER SCIENTIFIC

    • ILLUMINA

    • GE HEALTHCARE

    • EPPENDORF

    • DANAHER

    • AGILENT TECHNOLOGIES

    • BGI

    By Type:

    • Sequencing

    • Microarray

    • PCR

    By End-User:

    • Functional Genomics

    • Epigenomics

    • Biomarkers Discovery

    • Pathway Analysis

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Korea Genomics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Korea Genomics Outlook to 2028- Original Forecasts

    • 2.2 Korea Genomics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Korea Genomics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Korea Genomics Market- Recent Developments

    • 6.1 Korea Genomics Market News and Developments

    • 6.2 Korea Genomics Market Deals Landscape

    7 Korea Genomics Raw Materials and Cost Structure Analysis

    • 7.1 Korea Genomics Key Raw Materials

    • 7.2 Korea Genomics Price Trend of Key Raw Materials

    • 7.3 Korea Genomics Key Suppliers of Raw Materials

    • 7.4 Korea Genomics Market Concentration Rate of Raw Materials

    • 7.5 Korea Genomics Cost Structure Analysis

      • 7.5.1 Korea Genomics Raw Materials Analysis

      • 7.5.2 Korea Genomics Labor Cost Analysis

      • 7.5.3 Korea Genomics Manufacturing Expenses Analysis

    8 Global Korea Genomics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Korea Genomics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Korea Genomics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Korea Genomics Market Outlook by Types and Applications to 2022

    • 9.1 Global Korea Genomics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Microarray Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global PCR Consumption and Growth Rate (2017-2022)

    • 9.2 Global Korea Genomics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Functional Genomics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Epigenomics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Biomarkers Discovery Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pathway Analysis Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Korea Genomics Market Analysis and Outlook till 2022

    • 10.1 Global Korea Genomics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Korea Genomics Consumption (2017-2022)

      • 10.2.2 Canada Korea Genomics Consumption (2017-2022)

      • 10.2.3 Mexico Korea Genomics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Korea Genomics Consumption (2017-2022)

      • 10.3.2 UK Korea Genomics Consumption (2017-2022)

      • 10.3.3 Spain Korea Genomics Consumption (2017-2022)

      • 10.3.4 Belgium Korea Genomics Consumption (2017-2022)

      • 10.3.5 France Korea Genomics Consumption (2017-2022)

      • 10.3.6 Italy Korea Genomics Consumption (2017-2022)

      • 10.3.7 Denmark Korea Genomics Consumption (2017-2022)

      • 10.3.8 Finland Korea Genomics Consumption (2017-2022)

      • 10.3.9 Norway Korea Genomics Consumption (2017-2022)

      • 10.3.10 Sweden Korea Genomics Consumption (2017-2022)

      • 10.3.11 Poland Korea Genomics Consumption (2017-2022)

      • 10.3.12 Russia Korea Genomics Consumption (2017-2022)

      • 10.3.13 Turkey Korea Genomics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Korea Genomics Consumption (2017-2022)

      • 10.4.2 Japan Korea Genomics Consumption (2017-2022)

      • 10.4.3 India Korea Genomics Consumption (2017-2022)

      • 10.4.4 South Korea Korea Genomics Consumption (2017-2022)

      • 10.4.5 Pakistan Korea Genomics Consumption (2017-2022)

      • 10.4.6 Bangladesh Korea Genomics Consumption (2017-2022)

      • 10.4.7 Indonesia Korea Genomics Consumption (2017-2022)

      • 10.4.8 Thailand Korea Genomics Consumption (2017-2022)

      • 10.4.9 Singapore Korea Genomics Consumption (2017-2022)

      • 10.4.10 Malaysia Korea Genomics Consumption (2017-2022)

      • 10.4.11 Philippines Korea Genomics Consumption (2017-2022)

      • 10.4.12 Vietnam Korea Genomics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Korea Genomics Consumption (2017-2022)

      • 10.5.2 Colombia Korea Genomics Consumption (2017-2022)

      • 10.5.3 Chile Korea Genomics Consumption (2017-2022)

      • 10.5.4 Argentina Korea Genomics Consumption (2017-2022)

      • 10.5.5 Venezuela Korea Genomics Consumption (2017-2022)

      • 10.5.6 Peru Korea Genomics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Korea Genomics Consumption (2017-2022)

      • 10.5.8 Ecuador Korea Genomics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Korea Genomics Consumption (2017-2022)

      • 10.6.2 Kuwait Korea Genomics Consumption (2017-2022)

      • 10.6.3 Oman Korea Genomics Consumption (2017-2022)

      • 10.6.4 Qatar Korea Genomics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Korea Genomics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Korea Genomics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Korea Genomics Consumption (2017-2022)

      • 10.7.2 South Africa Korea Genomics Consumption (2017-2022)

      • 10.7.3 Egypt Korea Genomics Consumption (2017-2022)

      • 10.7.4 Algeria Korea Genomics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Korea Genomics Consumption (2017-2022)

      • 10.8.2 New Zealand Korea Genomics Consumption (2017-2022)

    11 Global Korea Genomics Competitive Analysis

    • 11.1 OXFORD NANOPORE TECHNOLOGIES

      • 11.1.1 OXFORD NANOPORE TECHNOLOGIES Company Details

      • 11.1.2 OXFORD NANOPORE TECHNOLOGIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 OXFORD NANOPORE TECHNOLOGIES Korea Genomics Main Business and Markets Served

      • 11.1.4 OXFORD NANOPORE TECHNOLOGIES Korea Genomics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 QIAGEN

      • 11.2.1 QIAGEN Company Details

      • 11.2.2 QIAGEN Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 QIAGEN Korea Genomics Main Business and Markets Served

      • 11.2.4 QIAGEN Korea Genomics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 EUROFINS SCIENTIFIC

      • 11.3.1 EUROFINS SCIENTIFIC Company Details

      • 11.3.2 EUROFINS SCIENTIFIC Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 EUROFINS SCIENTIFIC Korea Genomics Main Business and Markets Served

      • 11.3.4 EUROFINS SCIENTIFIC Korea Genomics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 BIO-RAD LABORATORIES

      • 11.4.1 BIO-RAD LABORATORIES Company Details

      • 11.4.2 BIO-RAD LABORATORIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 BIO-RAD LABORATORIES Korea Genomics Main Business and Markets Served

      • 11.4.4 BIO-RAD LABORATORIES Korea Genomics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 PACIFIC BIOSCIENCES OF CALIFORNIA

      • 11.5.1 PACIFIC BIOSCIENCES OF CALIFORNIA Company Details

      • 11.5.2 PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Main Business and Markets Served

      • 11.5.4 PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 F HOFFMANN-LA ROCHE

      • 11.6.1 F HOFFMANN-LA ROCHE Company Details

      • 11.6.2 F HOFFMANN-LA ROCHE Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 F HOFFMANN-LA ROCHE Korea Genomics Main Business and Markets Served

      • 11.6.4 F HOFFMANN-LA ROCHE Korea Genomics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 THERMO FISHER SCIENTIFIC

      • 11.7.1 THERMO FISHER SCIENTIFIC Company Details

      • 11.7.2 THERMO FISHER SCIENTIFIC Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 THERMO FISHER SCIENTIFIC Korea Genomics Main Business and Markets Served

      • 11.7.4 THERMO FISHER SCIENTIFIC Korea Genomics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 ILLUMINA

      • 11.8.1 ILLUMINA Company Details

      • 11.8.2 ILLUMINA Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 ILLUMINA Korea Genomics Main Business and Markets Served

      • 11.8.4 ILLUMINA Korea Genomics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 GE HEALTHCARE

      • 11.9.1 GE HEALTHCARE Company Details

      • 11.9.2 GE HEALTHCARE Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 GE HEALTHCARE Korea Genomics Main Business and Markets Served

      • 11.9.4 GE HEALTHCARE Korea Genomics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 EPPENDORF

      • 11.10.1 EPPENDORF Company Details

      • 11.10.2 EPPENDORF Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 EPPENDORF Korea Genomics Main Business and Markets Served

      • 11.10.4 EPPENDORF Korea Genomics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 DANAHER

      • 11.11.1 DANAHER Company Details

      • 11.11.2 DANAHER Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 DANAHER Korea Genomics Main Business and Markets Served

      • 11.11.4 DANAHER Korea Genomics Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 AGILENT TECHNOLOGIES

      • 11.12.1 AGILENT TECHNOLOGIES Company Details

      • 11.12.2 AGILENT TECHNOLOGIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 AGILENT TECHNOLOGIES Korea Genomics Main Business and Markets Served

      • 11.12.4 AGILENT TECHNOLOGIES Korea Genomics Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 BGI

      • 11.13.1 BGI Company Details

      • 11.13.2 BGI Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 BGI Korea Genomics Main Business and Markets Served

      • 11.13.4 BGI Korea Genomics Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Korea Genomics Market Outlook by Types and Applications to 2028

    • 12.1 Global Korea Genomics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Microarray Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global PCR Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Korea Genomics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Functional Genomics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Epigenomics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Biomarkers Discovery Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Pathway Analysis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Korea Genomics Market Analysis and Outlook to 2028

    • 13.1 Global Korea Genomics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Korea Genomics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Korea Genomics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Korea Genomics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.2 UK Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.5 France Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Korea Genomics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Korea Genomics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.3 India Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Korea Genomics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Korea Genomics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Korea Genomics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Korea Genomics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Korea Genomics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Korea Genomics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Korea Genomics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Korea Genomics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Korea Genomics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Korea Genomics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Korea Genomics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Korea Genomics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Korea Genomics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Korea Genomics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Korea Genomics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Korea Genomics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Korea Genomics

    • Figure of Korea Genomics Picture

    • Table Global Korea Genomics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Korea Genomics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Microarray Consumption and Growth Rate (2017-2022)

    • Figure Global PCR Consumption and Growth Rate (2017-2022)

    • Figure Global Functional Genomics Consumption and Growth Rate (2017-2022)

    • Figure Global Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure Global Biomarkers Discovery Consumption and Growth Rate (2017-2022)

    • Figure Global Pathway Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Korea Genomics Consumption by Country (2017-2022)

    • Table North America Korea Genomics Consumption by Country (2017-2022)

    • Figure United States Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Canada Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table Europe Korea Genomics Consumption by Country (2017-2022)

    • Figure Germany Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure UK Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Spain Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure France Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Italy Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Finland Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Norway Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Poland Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Russia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table APAC Korea Genomics Consumption by Country (2017-2022)

    • Figure China Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Japan Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure India Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table South America Korea Genomics Consumption by Country (2017-2022)

    • Figure Brazil Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Chile Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Peru Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table GCC Korea Genomics Consumption by Country (2017-2022)

    • Figure Bahrain Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Oman Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table Africa Korea Genomics Consumption by Country (2017-2022)

    • Figure Nigeria Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table Oceania Korea Genomics Consumption by Country (2017-2022)

    • Figure Australia Korea Genomics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Korea Genomics Consumption and Growth Rate (2017-2022)

    • Table OXFORD NANOPORE TECHNOLOGIES Company Details

    • Table OXFORD NANOPORE TECHNOLOGIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table OXFORD NANOPORE TECHNOLOGIES Korea Genomics Main Business and Markets Served

    • Table OXFORD NANOPORE TECHNOLOGIES Korea Genomics Product Portfolio

    • Table QIAGEN Company Details

    • Table QIAGEN Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Korea Genomics Main Business and Markets Served

    • Table QIAGEN Korea Genomics Product Portfolio

    • Table EUROFINS SCIENTIFIC Company Details

    • Table EUROFINS SCIENTIFIC Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table EUROFINS SCIENTIFIC Korea Genomics Main Business and Markets Served

    • Table EUROFINS SCIENTIFIC Korea Genomics Product Portfolio

    • Table BIO-RAD LABORATORIES Company Details

    • Table BIO-RAD LABORATORIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIO-RAD LABORATORIES Korea Genomics Main Business and Markets Served

    • Table BIO-RAD LABORATORIES Korea Genomics Product Portfolio

    • Table PACIFIC BIOSCIENCES OF CALIFORNIA Company Details

    • Table PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Main Business and Markets Served

    • Table PACIFIC BIOSCIENCES OF CALIFORNIA Korea Genomics Product Portfolio

    • Table F HOFFMANN-LA ROCHE Company Details

    • Table F HOFFMANN-LA ROCHE Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F HOFFMANN-LA ROCHE Korea Genomics Main Business and Markets Served

    • Table F HOFFMANN-LA ROCHE Korea Genomics Product Portfolio

    • Table THERMO FISHER SCIENTIFIC Company Details

    • Table THERMO FISHER SCIENTIFIC Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table THERMO FISHER SCIENTIFIC Korea Genomics Main Business and Markets Served

    • Table THERMO FISHER SCIENTIFIC Korea Genomics Product Portfolio

    • Table ILLUMINA Company Details

    • Table ILLUMINA Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ILLUMINA Korea Genomics Main Business and Markets Served

    • Table ILLUMINA Korea Genomics Product Portfolio

    • Table GE HEALTHCARE Company Details

    • Table GE HEALTHCARE Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE HEALTHCARE Korea Genomics Main Business and Markets Served

    • Table GE HEALTHCARE Korea Genomics Product Portfolio

    • Table EPPENDORF Company Details

    • Table EPPENDORF Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table EPPENDORF Korea Genomics Main Business and Markets Served

    • Table EPPENDORF Korea Genomics Product Portfolio

    • Table DANAHER Company Details

    • Table DANAHER Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table DANAHER Korea Genomics Main Business and Markets Served

    • Table DANAHER Korea Genomics Product Portfolio

    • Table AGILENT TECHNOLOGIES Company Details

    • Table AGILENT TECHNOLOGIES Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AGILENT TECHNOLOGIES Korea Genomics Main Business and Markets Served

    • Table AGILENT TECHNOLOGIES Korea Genomics Product Portfolio

    • Table BGI Company Details

    • Table BGI Korea Genomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BGI Korea Genomics Main Business and Markets Served

    • Table BGI Korea Genomics Product Portfolio

    • Figure Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microarray Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PCR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Functional Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biomarkers Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pathway Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Korea Genomics Consumption Forecast by Country (2022-2028)

    • Table North America Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure United States Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure Germany Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure China Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Korea Genomics Consumption Forecast by Country (2022-2028)

    • Figure Australia Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Korea Genomics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.